A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer (Q28943493)

14 March 2017

title

A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer (English)

1 reference

genome-wide association study

14 March 2017

main subject

0 references

1 reference

J.-Y. Han

1

1 reference

14 March 2017

E. S. Shin

2

1 reference

14 March 2017

Y.-S. Lee

3

1 reference

14 March 2017

H. Y. Ghang

4

1 reference

14 March 2017

S.-Y. Kim

5

1 reference

14 March 2017

J.-A. Hwang

6

1 reference

14 March 2017

J. Y. Kim

7

1 reference

14 March 2017

J. S. Lee

8

1 reference

14 March 2017

publication date

1 October 2013

1 reference

The Pharmacogenomics Journal

14 March 2017

published in

1 reference

14 March 2017

volume

13

1 reference

14 March 2017

5

10

0 references

page(s)

417–422

1 reference

describes a project that uses

14 March 2017

genome-wide association study

1 reference

based on heuristic

inferred from title

cites work

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 April 2017

1 reference

Genetic predictors of medically refractory ulcerative colitis

21 April 2017

1 reference

Genome-wide association meta-analysis for total serum bilirubin levels

21 April 2017

1 reference

A new multipoint method for genome-wide association studies by imputation of genotypes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Toxicity of irinotecan in patients with colorectal cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Genetic variations as cancer prognostic markers: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

PDZRN3 Negatively Regulates BMP-2–induced Osteoblast Differentiation through Inhibition of Wnt Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.24